Physician

Allison Maria Zibelli, MD

According to 2025 Medicare claims, Allison Zibelli, MD (NPI: 1205865094) practices medical oncology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is JEFFERSON UNIVERSITY PHYSICIANS (NPI: 1326093675; TIN: 232809585) and primary practice location at 19148-2912. Zibelli is affiliated with the Delaware Valley ACO (ACO ID: A2024) and Einstein Care Partners, LLC (ACO ID: A3671), participating under the MSSP model.

Zibelli's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 239 traditional Medicare patients, billed 516 HCPCS/CPT codes, and received $39,869 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,147 prescription claims across 268 beneficiaries totaling $3,176,972 in drug costs, led by Verzenio (Abemaciclib). DME data shows 14 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $108,148 to $39,869. In contrast, Part D prescription costs have risen steadily, from $752,365 to $3,176,972. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	295	6,272	$108,148
2016	352	6,644	$163,864
2017	1,140	1,920	$225,605
2018	239	683	$40,494
2019	215	3,565	$94,491
2020	192	531	$33,777
2021	224	553	$52,282
2022	196	437	$39,037
2023	216	406	$33,172
2024	239	516	$39,869

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	123	844	$752,365
2016	133	834	$716,487
2017	127	944	$1,021,224
2018	116	922	$776,887
2019	133	799	$1,035,271
2020	161	950	$1,194,845
2021	212	946	$1,169,141
2022	191	1,035	$2,143,735
2023	239	1,032	$3,268,924
2024	268	1,147	$3,176,972

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	26	$17,097
2016	N/R	31	$9,999
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	29	$2,465
2020	N/R	N/R	N/R
2021	N/R	89	$4,320
2022	N/R	41	$1,176
2023	N/R	66	$7,220
2024	N/R	14	$503

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	15	15	$137
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	43	144	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	125	183	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	72	91	$46
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	21	28	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	59	1,652	$757,845
Jakafi	Ruxolitinib Phosphate	40	1,200	$691,892
Ibrance	Palbociclib	37	1,036	$583,450
Tukysa	Tucatinib	11	330	$277,636
Venclexta	Venetoclax	34	994	$244,520

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	14	$503

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Allison Maria Zibelli, MD?

Tedicare shows public-source Medicare data for Allison Maria Zibelli, MD (NPI 1205865094), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allison Maria Zibelli, MD have ACO affiliation data?

Allison Maria Zibelli, MD is shown with ACO affiliation data for Delaware Valley ACO (MSSP, ACO ID A2024) and Einstein Care Partners, LLC (MSSP, ACO ID A3671).

What billing organization is linked to Allison Maria Zibelli, MD?

Allison Maria Zibelli, MD is linked to JEFFERSON UNIVERSITY PHYSICIANS (billing NPI 1326093675) in the available physician profile data.

Does Allison Maria Zibelli, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.